Invention Grant
- Patent Title: Azelaic acid esters in the treatment of insulin resistance
-
Application No.: US15491937Application Date: 2017-04-19
-
Publication No.: US10251857B2Publication Date: 2019-04-09
- Inventor: Robert T. Streeper , Elzbieta Izbicka
- Applicant: NEW FRONTIER LABS, LLC
- Applicant Address: US TX San Antonio
- Assignee: New Frontier Labs, LLC
- Current Assignee: New Frontier Labs, LLC
- Current Assignee Address: US TX San Antonio
- Agency: Pillsbury Winthrop Shaw Pittman
- Main IPC: A61K31/225
- IPC: A61K31/225 ; A61K31/573 ; A61K9/00 ; A61K45/06 ; A61K31/337
Abstract:
A method of treating insulin resistance includes administering to a subject a pharmaceutical composition comprising diethyl azelate. For example, a method of treating insulin resistance includes orally administering to a subject a pharmaceutical composition that includes diethyl azelate at a dosage range from about 0.1 mg/kg/day to about 10 mg/kg/day.
Public/Granted literature
- US20170304252A1 AZELAIC ACID ESTERS IN THE TREATMENT OF INSULIN RESISTANCE Public/Granted day:2017-10-26
Information query
